QL (chemical)

From WikiMD's WELLNESSPEDIA

QL is a chemical compound that is used as a stimulant in the central nervous system. It is also known as quinuclidinyl benzilate or BZ.

History[edit]

QL was first synthesized in the early 1950s by the United States Army Chemical Corps. It was developed as part of a program to create non-lethal incapacitating agents. The compound was tested on human subjects, with the results indicating that it could cause a range of effects, from mild sedation to complete unconsciousness.

Chemical Structure and Properties[edit]

QL is a quinuclidine derivative, with a benzilate moiety attached to the nitrogen atom. It is a white, crystalline solid that is soluble in water and most organic solvents. The compound has a high boiling point and a low melting point, making it suitable for use in a variety of applications.

Effects[edit]

The effects of QL are primarily due to its action as a muscarinic antagonist. This means that it blocks the action of acetylcholine, a neurotransmitter that is involved in many functions of the body, including the regulation of heart rate, digestion, and salivation. By blocking the action of acetylcholine, QL can cause a range of effects, including dry mouth, blurred vision, increased heart rate, and confusion.

Uses[edit]

QL has been used in a variety of applications, including as a chemical warfare agent and as a psychoactive drug. However, its use in these contexts is highly controversial and is subject to strict regulation.

See Also[edit]

References[edit]


QL (chemical)[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.